MIOSTAT- carbachol solution United States - English - NLM (National Library of Medicine)

miostat- carbachol solution

alcon laboratories, inc. - carbachol (unii: 8y164v895y) (carbamoylcholine - unii:54z8m50d6q) - carbachol 0.1 mg in 1 ml - intraocular use for obtaining miosis during surgery. in addition, miostat* (carbachol intraocular solution, usp) 0.01% reduces the intensity of iop elevation in the first 24 hours after cataract surgery. should not be used in those persons showing hypersensitivity to any of the components of this preparation. safety and efficacy in pediatric patients have not been established. no overall differences in safety or effectiveness have been observed between elderly and younger patients.

Lipostat 20mg tablets United Kingdom - English - myHealthbox

lipostat 20mg tablets

bristol myers squibb pharmaceuticals ltd. - pravastatin sodium - tablets - 20 mg - serum lipid reducing agents/cholesterol and triglyceride reducers/hmg-coa reductase inhibitors - treatment of primary hypercholesterolaemia or mixed dyslipidaemia, as an adjunct to diet, when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate; reduction of cardiovascular mortality and morbidity in patients with moderate or severe hypercholesterolaemia and at high risk of a first cardiovascular event, as an adjunct to diet: reduction of cardiovascular mortality and morbidity in patients with a history of myocardial infarction (mi) or unstable angina pectoris and with either normal or increased cholesterol levels, as an adjunct to correction of other risk factors; reduction of post transplantation hyperlipidaemia in patients receiving immunosuppressive therapy following solid organ transplantation

Lipostat 40mg tablets United Kingdom - English - myHealthbox

lipostat 40mg tablets

bristol myers squibb pharmaceuticals ltd. - pravastatin sodium - tablets - 40mg - serum lipid reducing agents/cholesterol and triglyceride reducers/hmg-coa reductase inhibitors - treatment of primary hypercholesterolaemia or mixed dyslipidaemia, as an adjunct to diet, when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate; reduction of cardiovascular mortality and morbidity in patients with moderate or severe hypercholesterolaemia and at high risk of a first cardiovascular event, as an adjunct to diet; reduction of cardiovascular mortality and morbidity in patients with a history of myocardial infarction (mi) or unstable angina pectoris and with either normal or increased cholesterol levels, as an adjunct to correction of other risk factors; reduction of post transplantation hyperlipidaemia in patients receiving immunosuppressive therapy following solid organ transplantation.

Lipostat 10mg tablets United Kingdom - English - myHealthbox

lipostat 10mg tablets

bristol myers squibb pharmaceuticals ltd. - pravastatin sodium - tablets - 10mg - serum lipid reducing agents/cholesterol and triglyceride reducers/hmg-coa reductase inhibitors - treatment of primary hypercholesterolaemia or mixed dyslipidaemia, as an adjunct to diet, when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate; reduction of cardiovascular mortality and morbidity in patients with moderate or severe hypercholesterolaemia and at high risk of a first cardiovascular event, as an adjunct to diet; reduction of cardiovascular mortality and morbidity in patients with a history of myocardial infarction (mi) or unstable angina pectoris and with either normal or increased cholesterol levels, as an adjunct to correction of other risk factors; reduction of post transplantation hyperlipidaemia in patients receiving immunosuppressive therapy following solid organ transplantation.

NITROSTAT TABLET Canada - English - Health Canada

nitrostat tablet

bgp pharma ulc - nitroglycerin - tablet - 0.6mg - nitroglycerin 0.6mg - nitrates and nitrites

NITROSTAT TABLET Canada - English - Health Canada

nitrostat tablet

bgp pharma ulc - nitroglycerin - tablet - 0.3mg - nitroglycerin 0.3mg - nitrates and nitrites

Miostat intraocular New Zealand - English - Medsafe (Medicines Safety Authority)

miostat intraocular

alcon laboratories (new zealand) limited - carbachol 0.01%{relative} - solution for injection - 0.01 % - active: carbachol 0.01%{relative} excipient: calcium chloride dihydrate hydrochloric acid magnesium chloride hexahydrate potassium chloride sodium acetate trihydrate sodium chloride sodium citrate dihydrate sodium hydroxide water for injection